Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 11;321(22):2231-2232.
doi: 10.1001/jama.2019.5453.

Hip Fractures in Older Adults in 2019

Sarah D Berry  1   2 , Douglas P Kiel  1   2 , Cathleen Colón-Emeric  3
Affiliations
Review

Hip Fractures in Older Adults in 2019

Sarah D Berry et al. JAMA. .

Erratum in

  • Error in Figure.
    [No authors listed] [No authors listed] JAMA. 2019 Sep 17;322(11):1108. doi: 10.1001/jama.2019.12264. JAMA. 2019. PMID: 31528987 Free PMC article. No abstract available.

Corrected and republished in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Drs. Kiel and Berry received royalties for Wolters-Kluwer for a chapter on falls. Dr. Colón -Emeric has no conflicts of interest to declare.

Figures

Figure:
Figure:
Managing Medications in Older Adults at Risk for Fracture aStage IV chronic kidney disease: creatinine clearance 15–29 mL/min; stage V chronic kidney disease: creatinine clearance <15 mL/min or receiving dialysis.
See this image and copyright information in PMC

Comment in

References

    1. Tajeu GS, Delzell E, Smith W, et al. Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci. 2014;69(3):346–353. - PMC - PubMed
    1. Viswanathan M, Reddy S, Berkman N, et al. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319(24):2532–2551. - PubMed
    1. Drugs for Postmenopausal Osteoporosis. The Medical Letter on Drugs and Therapeutics. 2017;59(1536):203–210. - PubMed
    1. Pham AN, Datta SK, Weber TJ, Walter LC, Colón-Emeric CS. Cost-Effectiveness of Oral Bisphosphonates for Osteoporosis at Different Ages and Levels of Life Expectancy. Journal of the American Geriatrics Society. 2011;59(9):1642–1649. - PubMed
    1. Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008(1):CD001155. - PubMed

Substances